Treatment & Drugs

Treatments for Macular Degeneration

If you are diagnosed with age-related macular degeneration (AMD), you need to see your eye doctor regularly to determine how quickly your disease is progressing. Your doctor can:

  • Tell you how to control risk factors for AMD
  • Show you how to use the Amsler grid, a simple method by which you can regularly monitor and detect any subtle changes in your vision on your own

At the first sign of any visual changes—no matter how small they may seem—you should make an appointment with your eye care provider.

Treatments for Dry Macular Degeneration

Treatments Wet Macular Degeneration

Potential Treatments for Macular Degeneration

Researchers are investigating many potential treatments for AMD and testing them in human clinical trials. For snapshots of clinical trials, explore Antidote, a search engine that can find a trial that’s right for you.

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me imformed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.

Related Experts & Advice

  • Prescription Pad
    Expert

    Prescription Medications That Can Affect Age-Related Macular Degeneration

    Patients often ask if their medications affect the risk of vision loss from age-related macular degeneration (AMD). One class of medications can lead to more severe vision loss in people with the wet form of the disease, and another class of drugs may have a beneficial effect.

    Wednesday, February 1, 2017
  • Acupuncturist teaching a class.
    Expert

    Alternative Medicine for Macular Degeneration: Does it Work?

    Some patients with age-related macular degeneration (AMD) look to alternative medicine for prevention options. While there is strong evidence that certain vitamins and diets can reduce your risk of vision disease, other approaches, such as rheophoresis, microcurrent stimulation, and acupuncture are unproven at present.

    Tuesday, January 3, 2017